Table 1.
Initial criteria, their respective categories, and initial weights assigned to each category*
Criterion and category | Score |
---|---|
Joint involvement (pattern and distribution) | |
1 medium-large joint | 0.0 |
Asymmetric medium-large joints (at least 2 joints) | 12.3 |
Symmetric medium-large joints (at least 2 joints) | 20.0 |
1–3 small joints (hands/feet or wrists) | 26.2 |
≥4 asymmetric small joints (hands/feet or wrists) | 35.4 |
≥4 symmetric small joints (hands/feet or wrists) | 36.9 |
Serology (ACPA or RF) | |
RF negative and ACPA negative | 0.0 |
Low-positive (RF positive and/or ACPA positive) | 27.0 |
High-positive (RF positive and/or ACPA positive) | 43.1 |
Acute-phase reactants (CRP or ESR) | |
Normal | 0.0 |
Abnormal | 7.7 |
Duration of synovitis | |
<4 weeks | 0.0 |
4–8 weeks | 10.8 |
>8 weeks | 12.3 |
Scores from each criterion are summed to derive the total score, which represents the probability of developing rheumatoid arthritis (RA).
ACPA = anti–cyclic citrullinated protein; RF = rheumatoid factor; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate.